BioCentury
ARTICLE | Financial News

KV Pharmaceutical financial update

August 13, 2012 7:00 AM UTC

KV said it received notice from NYSE that trading of its class A and B common shares was halted and that the shares were delisted following the company's voluntary Aug. 4 filing for Chapter 11 bankrup...